ID: ALA4744507

Max Phase: Preclinical

Molecular Formula: C13H10N4O2S

Molecular Weight: 286.32

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccc2nnsc2c1)N(O)c1ccccc1

Standard InChI:  InChI=1S/C13H10N4O2S/c18-13(17(19)10-4-2-1-3-5-10)14-9-6-7-11-12(8-9)20-16-15-11/h1-8,19H,(H,14,18)

Standard InChI Key:  YJYZCPIQZWSNDF-UHFFFAOYSA-N

Associated Targets(Human)

Bromodomain adjacent to zinc finger domain protein 1A 48 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 286.32Molecular Weight (Monoisotopic): 286.0524AlogP: 3.12#Rotatable Bonds: 2
Polar Surface Area: 78.35Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.65CX Basic pKa: CX LogP: 2.83CX LogD: 2.80
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.56Np Likeness Score: -1.75

References

1. Yang Z,Zhou Y,Zhong L.  (2021)  Discovery of BAZ1A bromodomain inhibitors with the aid of virtual screening and activity evaluation.,  33  [PMID:33333161] [10.1016/j.bmcl.2020.127745]

Source